IntegriChain Acquires PharmaMetrics

IntegriChain, a healthcare technology company, has acquired PharmaMetrics, a provider of contract operations outsourcing and market access analytics software and services.

IntegriChain says the acquisition strengthens its ability to deliver analytics and contract management solutions to pharmaceutical managed markets teams in support of their growing investments in patient access. This is IntegriChain's first acquisition since entering its strategic partnership with Accel-KKR, a technology-focused private equity firm, in 2016.

The acquisition supports IntegriChain’s vision to bring together disparate commercial data assets into one enrichment and analytics platform with capabilities to help solve some of the pharmaceutical industry's hardest contracting and patient journey challenges, said IntegriChain co-founder and CEO Kevin Leininger.

With the addition of PharmaMetrics' market access expertise and capabilities to the IntegriChain platform, he noted, IntegriChain can widen its focus to deliver analytics and solutions that allow pharmaceutical companies to balance the cost and efficacy of their pharmacy network, patient services, and co-pay assistance strategies.

For more information, visit www.pharmametricsinc.com.